The core function of the human stomach is as an aid to digestion. The four key components of gastric digestive function are its function as a reservoir, acid secretion, enzyme secretion and its role in gastrointestinal motility. The reservoir capacity of the stomach allows it to increase its volume significantly while internal pressure increases only slightly. Acid secretion is a very important non-immunological defence against invading pathogens as well as being an important mechanism for vertebrates to have more complex diets. Stimulation of acid secretion involves the translocation of H+/K+-ATPases to the apical membrane of the parietal cell. The stomach is also an important endocrine organ producing an array of peptide hormones important for both enteric and non-enteric physiology including ghrelin and leptin. In addition to the reservoir function, the stomach also plays an important motility role as a pump, which anatomically is provided by the distal two thirds of the corpus, the antrum and the pylorus. This article examines those four functions and the role that they play in normal physiologic function and examines how they may play a role in pathologic states.

1.
Granström L, Backman L: Stomach distension in extremely obese and in normal subjects. Acta Chir Scand 1985;151:367-370.
2.
Geliebter A, Westreich S, Gage D: Gastric distention by balloon and test-meal intake in obese and lean subjects. Am J Clin Nutr 1988;48:592-594.
3.
Yanovski SZ: Binge eating disorder: current knowledge and future directions. Obes Res 1993;1:306-324.
4.
El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE: Helicobacterpylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
5.
Jeffery PL, McGuckin MA, Linden SK: Endocrine impact of Helicobacterpylori: focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol 2011;17:1249-1260.
6.
Lewin D, Lewin K (eds): Stomach: Normal Anatomy and Histology. Baltimore, Lippincott Williams & Wilkins, 1999.
7.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656-660.
8.
Maciorkowska E, Panasiuk A, Kondej-Muszyńska K, Kaczmarski M, Kemona A: Mucosal gastrin cells and serum gastrin levels in children with Helicobacterpylori infection. Adv Med Sci 2006;51:137-141.
9.
Dzierzanowska-Fangrat K, Michalkiewicz J, Cielecka-Kuszyk J, Nowak M, Celinska-Cedro D, Rozynek E, Dzierzanowska D, Crabtree JE: Enhanced gastric IL-18 mRNA expression in Helicobacterpylori-infected children is associated with macrophage infiltration, IL-8, and IL-1 beta mRNA expression. Eur J Gastroenterol Hepatol 2008;20:314-319.
10.
Nwokolo CU, Freshwater DA, O'Hare P, Randeva HS: Plasma ghrelin following cure of Helicobacterpylori. Gut 2003;52:637-640.
11.
Cho I, Blaser MJ, François F, Mathew JP, Ye XY, Goldberg JD, Bini EJ: Helicobacterpylori and overweight status in the United States: data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2005;162:579-584.
12.
Chew CS, Hersey SJ, Sachs G, Berglindh T: Histamine responsiveness of isolated gastric glands. Am J Physiol 1980;238:G312-G320.
13.
Uvnas B: The part played by the pyloric region in the cephalic phase of gastric secretion. Acta Physiol Scan 1942;4(suppl 13):1-7.
14.
Samloff IM: Pepsinogens, pepsins, and pepsin inhibitors. Gastroenterology 1971;60:586-604.
15.
Samloff IM: Cellular localization of group I pepsinogens in human gastric mucosa by immunofluorescence. Gastroenterology 1971;61:185-188.
16.
Samloff IM, Liebman WM: Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence. Gastroenterology 1973;65:36-42.
17.
Bornschein J, Selgrad M, Wex T, Kuester D, Malfertheiner P: Serological assessment of gastric mucosal atrophy in gastric cancer. BMC Gastroenterol 2012;12:10.
18.
Buyse M, Ovesjo ML, Goiot H, Guilmeau S, Peranzi G, Moizo L, et al: Expression and regulation of leptin receptor proteins in afferent and efferent neurons of the vagus nerve. Eur J Neurosci 2001;14:64-73.
19.
Asakawa A, Inui A, Ueno N, Makino S, Fujino MA, Kasuga M: Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 1999;116:1287.
20.
Kiely JM, Noh JH, Graewin SJ, Pitt HA, Swartz-Basile DA: Altered intestinal motility in leptin-deficient obese mice. J Surg Res 2005;124:98-103.
21.
Martinez V, Barrachina MD, Wang L, Tache Y: Intracerebroventricular leptin inhibits gastric emptying of a solid nutrient meal in rats. Neuroreport 1999;10:3217.
22.
Hata N, Murata S, Maeda J, Yatani H, Kohno Y, Yokono K, Okano H: Predictors of gastric myoelectrical activity in type 2 diabetes mellitus. J Clin Gastroenterol 2009;43:429-436.
23.
Guilmeau S, Buyse M, Tsocas A, Laigneau JP, Bado A: Duodenal leptin stimulates cholecystokinin secretion evidence of a positive leptin-cholecystokinin feedback loop. Diabetes 2003;52:1664-1672.
24.
Gaigé S, Abysique A, Bouvier M: Effects of leptin on cat intestinal motility. J Physiol 2003;546:267-277.
25.
Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP: Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001;121:79-90.
26.
Molina A, Pita A, Farriol M, Virgili N, Soler J, Gómez JM: Serum leptin concentrations in patients with short-bowel syndrome. Clin Nutr 2000;19:333-338.
27.
D'Souza AL: Ageing and the gut. Postgrad Med J 2007;83:44-53.
28.
Salles N, Mégraud F: Current management of Helicobacter pylori infections in the elderly. Expert Rev Anti Infect Ther 2007;5:845-856.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.